HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-12
DOI
10.1038/s41598-019-48212-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of HER2 status in breast cancer biopsies is not affected by accelerated tissue processing
- (2018) Joris P Bulte et al. HISTOPATHOLOGY
- Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer
- (2018) Nicole C. M. Visser et al. VIRCHOWS ARCHIV
- Brief fixation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors, E-cadherin and HER2/Neu
- (2017) Altuna Halilovic et al. JOURNAL OF CLINICAL PATHOLOGY
- Frequency of chromosome 17 polysomy in relation to CEP17 copy number in a large breast cancer cohort
- (2016) Vladimira Koudelakova et al. GENES CHROMOSOMES & CANCER
- Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
- (2016) John M. S. Bartlett et al. JNCI-Journal of the National Cancer Institute
- Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
- (2016) John M. S. Bartlett et al. JNCI-Journal of the National Cancer Institute
- Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer
- (2015) António E. Pinto et al. BREAST
- Guidelines for cytogenetic investigations in tumours
- (2015) Rosalind J Hastings et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Loss of KLF14 triggers centrosome amplification and tumorigenesis
- (2015) Guangjian Fan et al. Nature Communications
- Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells
- (2014) Milena Rondón-Lagos et al. BMC CANCER
- Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
- (2014) Ariadna Tibau et al. NEOPLASIA
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
- (2013) Wedad M Hanna et al. MODERN PATHOLOGY
- Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells
- (2013) P Cappello et al. ONCOGENE
- Centrosome Dysfunction Contributes to Chromosome Instability, Chromoanagenesis, and Genome Reprograming in Cancer
- (2013) German A. Pihan Frontiers in Oncology
- Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial
- (2011) Kathleen I. Pritchard et al. BREAST CANCER RESEARCH AND TREATMENT
- Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer
- (2011) Zsuzsanna Varga et al. BREAST CANCER RESEARCH AND TREATMENT
- Determining TrueHER2Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2Targeted Therapy
- (2011) Chun Hing Tse et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity
- (2010) Shelly Gunn et al. BMC CANCER
- Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17
- (2010) Semir Vranic et al. CANCER
- Chromosome 17 Polysomy without Human Epidermal Growth Factor Receptor 2 Amplification Does Not Predict Response to Lapatinib Plus Paclitaxel Compared with Paclitaxel in Metastatic Breast Cancer
- (2010) L. Downey et al. CLINICAL CANCER RESEARCH
- Simultaneous assessment of DNA ploidy and biomarker expression in paraffin-embedded tissue sections
- (2010) Stijn J H M Fleskens et al. HISTOPATHOLOGY
- Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification
- (2009) Cathy B. Moelans et al. BREAST CANCER RESEARCH AND TREATMENT
- Disease-Free Survival According to Degree ofHER2Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
- (2009) Heikki Joensuu et al. JOURNAL OF CLINICAL ONCOLOGY
- Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescencein situhybridization and microarray-based CGH analysis
- (2009) Caterina Marchiò et al. JOURNAL OF PATHOLOGY
- Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response
- (2009) Monica M Reinholz et al. LANCET ONCOLOGY
- Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event
- (2009) I-Tien Yeh et al. MODERN PATHOLOGY
- Evaluation of centrosome abnormalities and p53 inactivation in chemical induced hepatocellular carcinogenesis
- (2009) Y. Chen et al. NEOPLASMA
- Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
- (2008) Isabelle Vanden Bempt et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search